«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:

2019年03期

页码:

1-9

栏目:

实验研究

出版日期:

2020-04-20

文章信息/Info

Title:

The Effect of Nobiletin on Hepatocyte Apoptosis in Rat Model of Non-alcoholic Fatty Liver Disease

文章编号:

1000-2723（2019）03-0001-09

作者:

石安华¹; 2; 范英昌¹; 姚 政²; 武俊紫²; 何朋伦²; 王 维²; 周青丽²; 陈文慧^2△

（1. 天津中医药大学，天津 300193；2. 云南中医药大学，云南 昆明 650500）

Author(s):

SHI Anhua¹; 2;  FAN Yingchang¹;  YAO Zheng²;  WU Junzi²;  HE Penglun²;  WANG Wei²;  ZHOU Qingli²;  CHEN Wenhui²

(1. Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; 2. Yunnan University of Chinese Medicine, Kunming 650500, China)

关键词:

川陈皮素;  非酒精性脂肪性肝病; 大鼠;  凋亡相关蛋白

Keywords:

Nobiletin;  nonalcoholic fatty liver disease;  rat;  apoptosis-related protein

分类号:

R285.5

DOI:

10.19288/j.cnki.issn.1000-2723.2019.03.001

文献标识码:

A

摘要:

目的从肝细胞凋亡途径研究川陈皮素对非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD)大鼠的保护作用。方法 适应性喂养2周后，72只SD大鼠随机分成6组，分别为正常对照组、模型组、阳性药物水飞蓟素片治疗组（14 mg/kg），以及川陈皮素低（100 mg/kg）、中（200 mg/kg）、高剂量（400 mg/kg）组，高脂高糖饮食8周构建NAFLD模型，治疗6周后，HE染色观察肝脏病理变化，计算肝指数，取血清检测ALT、AST、TC、TG、LDL-C、HDL-C、IL-1a、IL-1b和IL-6的含量，Western blot和qRT-PCR法测定肝组织TNF-α、TNFR-1、Fas、FasL、Caspase-8、Caspase-3、Bcl-2和Bax的蛋白及mRNA表达水平。结果 正常组大鼠精神活跃，模型组在造模成功后精神萎靡，水飞蓟素片治疗组以及川陈皮素低、中、高剂量组相较于模型组有一定好转。与正常组相比，模型组大鼠肝湿重、肝指数、ALT、AST、TG、TC、LDL-C、IL-1a、IL-1b、IL-6明显升高（P<0.05），HDL-C明显降低（P<0.05）；相较于模型组，水飞蓟素片治疗组及川陈皮素低、中、高剂量组肝湿重、肝指数、ALT、AST、TG、TC、LDL-C、IL-1a、IL-1b、IL-6明显降低（P<0.05），HDL-C明显升高（P<0.05）；此外川陈皮素高剂量组肝指数、ALT、AST、IL-1a、IL-1b、IL-6明显低于水飞蓟素片治疗组（P<0.05）；川陈皮素中剂量和高剂量组TG、TC、LDL-C明显低于水飞蓟素片治疗组（P<0.05），中剂量和高剂量组HDL-C明显高于水飞蓟素片治疗组（P<0.05），体重各组间没有明显差异。与正常组相比，模型组TNF-α、TNFR-1、FasL、Fas、Bax、Caspase-8、Caspase-3蛋白和mRNA表达水平明显升高（P<0.05），Bcl-2蛋白和mRNA表达明显降低（P<0.05）；与模型组相比，水飞蓟素片治疗组、川陈皮素低、中、高剂量组TNF-α、TNFR-1、FasL、Fas、Caspase-8、Caspase-3蛋白和mRNA表达明显降低（P<0.05），水飞蓟素片治疗组、川陈皮素低、中、高剂量组Bcl-2表达明显升高（P<0.05）。结论 川陈皮素对高脂饮食诱导的非酒精性脂肪性肝病大鼠肝脏具有明显的保护作用，其作用途径可能与川陈皮素调节凋亡相关蛋白表达，降低炎症反应有关。

Abstract:

Objective To study the protective effect of nobiletin on hepatocyte apoptosis in rat model of nonalcoholic fatty liver disease (NAFLD). Methods 72 SD rats were randomly divided into 6 groups: the control group, model group, positive drug silymarin treatment group (14 mg/kg), and nobiletin low dose (100 mg/kg), medium dose (200 mg/kg) and high dose (400 mg/kg) treatment groups. NAFLD rat model was established by high-fat diet for 8 weeks followed by 6 weeks of treatment. After scarification the liver pathology was evaluated by HE staining, liver index was calculated, and serum levels of ALT, AST, TC, TG, LDL-C, HDL-C, IL-1a, IL-1b and IL-6 were measured. Protein expression and mRNA levels of TNF-α, TNFR-1, Fas, FasL, caspase-8, caspase-3, Bcl-2 and Bax in liver tissue were detected by Western Blot and qRT-PCR. Results Compared with the control group, rats in model group were apathetic, and rats in the silymarin group, low dose, medium dose and high dose nobiletin groups were obviously alleviated. In the model group, increase of the liver wet weight, liver index, ALT, AST, TG, TC, LDL-C, IL-1a, IL-1b and IL-6, also decrease of HDL-C(P<0.05) was observed. Compared with the model group, the liver wet weight, liver index, ALT, AST, TG, TC, LDL-C, IL-1a, IL-1b and IL-6 in the silymarin group and the low dose, medium dose and high dose nobiletin groups were significantly decreased (P<0.05) along with significant increase of HDL-C(P<0.05). In addition, the liver index, ALT, AST, IL-1a, IL-1b and IL-6 in the high dose nobiletin group were significantly lower than that of the silymarin group(P<0.05), and the TG, TC and LDL-C in the middle dose and high dose nobiletin groups were significantly lower than that of the silymarin group(P<0.05), while HDL-C in the middle dose and high dose nobiletin groups were significantly higher than that of the silymarin group(P<0.05). There were no significant difference in the body weight. In the model group, TNF-α, TNFR-1, FasL, Fas, Bax, caspase-8 and caspase-3 protein and mRNA levels were significantly increased(P<0.05), and Bcl-2 protein and mRNA levels were significantly declined (P<0.05). Compared with the model group, the TNF-α, TNFR-1, FasL, Fas, caspase-8 and caspase-3 protein and mRNA levels were significantly decreased in the silymarin and the low dose, medium dose and high dose nobiletin groups(P<0.05), and the expression of Bcl-2 in the silymarin treatment group and the low dose, medium dose and high dose nobiletin groups were significantly increased(P<0.05). Conclusion The nobiletin has obvious protective effect on the NAFLD rats induced by high-fat diet, and the mechanism of action was attribute to the inhibition of nobiletin in apoptosis-related proteins expression and inflammatory response.

参考文献/References

[1] CALZADILLA B L，ADAMS L A. The natural course of non-alcoholic fatty liver disease[J]. International Journal of Molecular Sciences，2016，17（5）：E774.
[2] 张海博，王宇. 非酒精性脂肪肝的现代研究进展[J].海南医学，2017，28（10）：1651-1653.
[3] PAIS R，RATZIU V. Epidemiology and natural history of nonalcoholic fatty liver disease[J]. La Revue Du Praticien，2012，62（10）：1416-1418.
[4] 李慧卿，苏少慧，宋娟. 非酒精性脂肪肝中西医治疗新进展[J]. 临床荟萃，2016，31（9）：1042-1044.
[5] 周晓黎，舒磊，石拓，等. 银杏总黄酮对NAFLD大鼠生化指标及血清脂联素水平的影响[J].临床消化病杂志，2017，29（4）：231-235.
[6] 郑晓艳，陈育青. 风柜斗草黄酮治疗大鼠非酒精性脂肪肝的研究[J].江西中医药大学学报，2016，28（2）：84-87.
[7] LI W，WANG X，NIU X，et al. Protective effects of nobiletin against endotoxic shock in mice through inhibiting TNF-α，IL-6，and HMGB1 and regulating NF-κB pathway[J]. Inflammation，2016，39（2）：786-797.
[8] DA C，LIU Y，ZHAN Y，et al. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway[J]. Oncology Reports，2016，35（5）：2767-2774.
[9] 张红蕊，王耕银，崔昌萌，等. 川陈皮素对糖尿病大鼠认知功能障碍的影响[J]. 中国老年学杂志，2018，38（18）：4516-4519.
[10] 王一强，姜德民，张玉香. 现代医学对非酒精性脂肪肝发病机制及治疗的研究进展[J]. 卫生职业教育，2016，34（12）：144-145.
[11] GARCIA M C，LO I O，CRESPO J，et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease[J]. European Journal of Clinical Investigation，2014，44（1）：65-73.
[12] 喻琴，王丽. 非酒精性脂肪性肝病动物模型研究进展[J]. 西南医科大学学报，2016，39（3）：300-302.
[13] 苏琳，刘玉兰. 高糖饮食及高脂饮食建立非酒精性脂肪肝大鼠模型的比较[J]. 实验动物科学，2009，26（3）：14-17.
[14] 姜慧卿. 非酒精性脂肪性肝病的临床表现与病理学特点[J].中国全科医学，2007，10（24）：2030-2033.
[15] 叶喜德，黄兆胜，骆利平，等. 川陈皮素研究概括[J].江西中医药大学学报，2013，25（3）：42-45.
[16] 汪娇，蒋鹏，周建伟. 川陈皮素对非酒精性脂肪肝细胞的保护作用和lncLSTR的调控机制[J]. 中国病理生理杂志，2018，34（6）：1129-1133.
[17] 王文亮. 细胞凋亡研究进展[J]. 心脏杂志，2005，17（6）：603-606.
[18] LUO K X，ZHU Y F，ZHANG L X，et al. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases[J]. Journal of Viral Hepatitis，1997，4（5）：303-307.
[19] 张新星. 抗凋亡对非酒精性脂肪性肝病进展的影响及机制探讨[D]. 重庆：重庆医科大学，2005.
[20] JIANG X，TANG X，ZHANG P，et al. Cyanidin-3-O-β-glucoside protects primary mouse hepatocytes against high glucose-induced apoptosis by modulating mitochondrial dysfunction and the PI3K/Akt pathway[J]. Biochemical Pharmacology，2014，90（2）：135-144.
[21] 何双艳，李昌平，李鹏，等. Fas/FasL、Bcl-2/Bax、Caspase-8在大鼠非酒精性脂肪性肝病中的作用机制[J]. 世界华人消化杂志，2012，20（36）：3761-3766.

备注/Memo

备注/Memo:

收稿日期： 2019 - 04- 20
* 基金项目： 国家自然科学基金地区基金项目（81760818）；云南省中医药学分子生物学重点实验室资助
第一作者简介： 石安华（1977-），男，副教授，在读博士研究生，主要研究方向：中西医结合防治肝病基础研究。
△通信作者： 陈文慧，E-mail: cwh6581908@126.com

常用功能

更新日期/Last Update: 2020-05-06